Cargando…
Fli1 Downregulation in Scleroderma Myeloid Cells Has Profibrotic and Proinflammatory Effects
Scleroderma (SSc) is an autoimmune connective tissue disease characterized by immune dysregulation, vasculopathy, and fibrosis. We have previously demonstrated that low Fli1 expression in SSc fibroblasts and endothelial cells plays an important role in SSc pathogenesis. Cells of myeloid and lymphoid...
Autores principales: | Bujor, Andreea M., El Adili, Fatima, Parvez, Arshi, Marden, Grace, Trojanowska, Maria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7248379/ https://www.ncbi.nlm.nih.gov/pubmed/32508810 http://dx.doi.org/10.3389/fimmu.2020.00800 |
Ejemplares similares
-
Ciprofloxacin has antifibrotic effects in scleroderma fibroblasts via downregulation of Dnmt1 and upregulation of Fli1
por: BUJOR, ANDREEA M., et al.
Publicado: (2012) -
Periostin overexpression in scleroderma cardiac tissue and its utility as a marker for disease complications
por: El-Adili, Fatima, et al.
Publicado: (2022) -
Correction: Periostin overexpression in scleroderma cardiac tissue and its utility as a marker for disease complications
por: El-Adili, Fatima, et al.
Publicado: (2023) -
FLI1 and ERG protein degradation is regulated via Cathepsin B lysosomal pathway in human dermal microvascular endothelial cells
por: Mazzotta, Celestina, et al.
Publicado: (2020) -
Immune complexes containing scleroderma-specific autoantibodies induce a profibrotic and proinflammatory phenotype in skin fibroblasts
por: Raschi, Elena, et al.
Publicado: (2018)